생명과학회지 (Journal of Life Science)

  • 제17권1호
  • /
  • Pages.45-50
  • /
  • 2007
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

FADD 과발현 평활근세포에서 분비하는 Turner Necrosis Factor-α의 작용

Biological Activity of Tumor Necrosis Factor-α Secreted from Smooth Muscle Cell Overexpressing FADD

  • 김선미 (부산대학교 의학전문대학원 약리학교실) ;
  • 이경아 (부산대학교 의학전문대학원 약리학교실) ;
  • 김관회 (부산대학교 의학전문대학원 약리학교실)
  • Kim, Sun-Mi (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Lee, Kyeong-Ah (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Koan-Hoi (Department of Pharmacology, School of Medicine, Pusan National University)
  • 발행 : 2007.01.29
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

세포 배양액에 tetracycline이 없는 경우 FADD를 발현하면서 사멸하는 평활근세포 (FADD-SMC)에서 분비하는 $TNF-\alpha$의 활성을 조사하였다. 배양액에 tetracycline이 없는 경우 FADD-SMC는 약 1000 pg/ml의 $TNF-\alpha$를 분비하였다. $TNF-\alpha$를 포함하는 배양액을 분리하고, 이 배양액을 정상세포에 처리한 결과 인산화한 p38 MAPK와 nuclear, factor, kappa B (NF-kB)의 활성이 증가하였다. 또한 이 배양액을 L929 세포에 처리하는 경우 세포독성이 발생하였다. NF-kB, p38 MAPK 그리고 L929 세포에 대찬 효과는 배양액에서 suluble TNF receptor를 이용하여 $TNF-\alpha$를 제거하는 경우 감소하였다.

This study investigated biological activity of tumor necrosis factor $(TNF)-\alpha$ secreted from smooth muscle cell (SMC) destined for death by expressing Fas associated death domain containing protein (FADD) (FADD-SMC) when the cells are grown without tetracycline in culture medium. In the absence of tetracycline the FADD-SMC secreted approximately 1000 pg/ml $TNF-\alpha$, whereas hardly detectable amount of the cytokine existed in the presence of tetracycline. The culture medium collected from the FADD-SMC grown in the absence of tetracycline increased phosphorylated form of p38 MAPK and up-regulated nuclear factor kappa B (NF-kB). The medium collected without tetracycline also caused death of L929 cells. Depletion of $TNF-\alpha$ with the soluble TNF receptor (sTNFR) inhibited the phosphorylation of p38 MAPK, the up-regulation of NF-kB activity and the death activity of the medium collected from FADD-SMC in the absence of tetracycline. These results indicate that $TNF-\alpha$ secreted from SMC undergoing death is biologically active and can affect cellular function.

키워드

참고문헌

  1. Baker S.J., E.P. Reddy 1998. Modulation of life and death by the TNF receptor superfamily. Oncogene 17, 3261-3270 https://doi.org/10.1038/sj.onc.1202568
  2. Bauriedel G., R. Hutter, U. Welsch, R. Bach, H. Sievert, B. Luderitz 1999. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 41, 480-488 https://doi.org/10.1016/S0008-6363(98)00318-6
  3. Bennett M.R. 1999. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 41, 361-368 https://doi.org/10.1016/S0008-6363(98)00212-0
  4. Biancone L., A.D. Martino, V. Orlandi, P.G. Conaldi, A. Toniolo, G. Camussi 1997. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp Med. 186, 147-152 https://doi.org/10.1084/jem.186.1.147
  5. Chinnaiyan A.M, V.M Dixit 1996. The cell-death machine. Curr. Biol. 6, 555-562 https://doi.org/10.1016/S0960-9822(02)00541-9
  6. Chinnaiyan A.M., K. O'Rourke, M. Tewari, V.M. Dixit 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell 81, 505-512 https://doi.org/10.1016/0092-8674(95)90071-3
  7. Chinnaiyan A.M., C.G. Tepper, M.F. Seldin 1996. FADD/MORT1 is a common mediator of CD 95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965 https://doi.org/10.1074/jbc.271.9.4961
  8. Cho A., D.W. Courtman, B.L. Langille 1995. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ. Res. 76, 168-175 https://doi.org/10.1161/01.RES.76.2.168
  9. Crisby M., B. Kallin, J. Thyberg 1997. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130, 17-27 https://doi.org/10.1016/S0021-9150(96)06037-6
  10. Flynn P.D., C.D. Byrne, T.P. Baglin, P.L. Weissberg, M.R. Bennett 1997. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 89, 4378-4384
  11. Henson P.M., D.L. Bratton, V.A. Fadok 2001. Apoptotic cell removal. Curr. Biol. 11, R795-805 https://doi.org/10.1016/S0960-9822(01)00474-2
  12. Idriss H.T., J.H. Naismith 2000. TNF alpha and the TNF receptor superfamily: structure-function relationship(s), Microsc. Res. Tech. 50, 184-195 https://doi.org/10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
  13. Kockx M.M. 1998. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18, 1519-1522 https://doi.org/10.1161/01.ATV.18.10.1519
  14. Kockx M.M., A.G. Herman 1998. Apoptosis in atherogenesis: implications for plaque destabilization. Eur. Heart J. 19 Suppl G, G23-28
  15. Kockx M.M., A.G. Herman 2000. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45, 736-746 https://doi.org/10.1016/S0008-6363(99)00235-7
  16. Libby P. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365-372 https://doi.org/10.1161/01.CIR.104.3.365
  17. MacEwan D.J. 2002. TNF ligands and receptors-a matter of life and death. Br. J. Pharmacol. 135, 855-875 https://doi.org/10.1038/sj.bjp.0704549
  18. Nagata S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55 https://doi.org/10.1146/annurev.genet.33.1.29
  19. Proudfoot D., J.N. Skepper, L. Hegyi, M.R. Bennett, C.M. Shanahan, P.L. Weissberg 2000. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 87, 1055-1062 https://doi.org/10.1161/01.RES.87.11.1055
  20. Schaub F.J., D.K. Han, W.C. Liles 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6, 790-796 https://doi.org/10.1038/77521
  21. Vaux D.L., S.J. Korsmeyer 1999. Cell death in development. Cell 96, 245-254 https://doi.org/10.1016/S0092-8674(00)80564-4
  22. Walsh C.M., B.G. Wen, A.M. Chinnaiyan, K. O'Rourke, V.M. Dixit, S.M. Hedrick 1998. A role for FADD in T cell activation and development. Immunity 8, 439-449 https://doi.org/10.1016/S1074-7613(00)80549-X